[
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca faz acordo para usar tecnologia de IA em medicamentos",
        "description":"Parceria fechada por US$ 18 milh\u00f5es permitir\u00e1 que a AstraZeneca use biotecnologia para testar a efic\u00e1cia de medicamentos contra o c\u00e2ncer\nO post AstraZeneca faz acordo para usar tecnologia de IA em medicamentos apareceu primeiro em Olhar Digital.",
        "content":"Os avan\u00e7os de intelig\u00eancia artificial tamb\u00e9m s\u00e3o cruciais para trazer progressos na \u00e1rea da sa\u00fade, e segundo informa\u00e7\u00f5es da Reuters, um novo acordo dever\u00e1 ser crucial para explorar o potencial da IA \u2026 [+1396 chars]",
        "url":"https:\/\/olhardigital.com.br\/2024\/09\/26\/medicina-e-saude\/astrazeneca-faz-acordo-para-usar-tecnologia-de-ia-em-medicamentos\/",
        "source":"Olhardigital.com.br",
        "published_at":1727397223000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999974966,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca says \u2018small number\u2019 of employees under investigation in China",
        "description":"Police reportedly probing five current and former employees over infringement of data privacy laws",
        "content":"Police reportedly probing five current and former employees over infringement of data privacy laws\r\nThis story appeared on ft.com, 2024-09-05.",
        "url":"https:\/\/biztoc.com\/x\/a0e59f9cfc7a590b",
        "source":"Biztoc.com",
        "published_at":1725526549000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9810277224,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Bloomberg: \u0432 \u041a\u0438\u0442\u0430\u0435 \u0431\u044b\u043b\u0438 \u0437\u0430\u0434\u0435\u0440\u0436\u0430\u043d\u044b \u0441\u043e\u0442\u0440\u0443\u0434\u043d\u0438\u043a\u0438 AstraZeneca",
        "description":"",
        "content":"vedomosti.ru\r\n, , , , - . \r\n ( , , \u00ab\u00bb, ). \r\n - \u00ab2\u00bb, vedomosti.ru\r\n \u00a9 , \/ 7712108141\/771501001, 1027739124775, 127018, . , ... , . , . 3, . 1 19992024",
        "url":"https:\/\/www.vedomosti.ru\/society\/news\/2024\/09\/05\/1060362-kitae-zaderzhani-sotrudniki-astrazeneca",
        "source":"Vedomosti.ru",
        "published_at":1725542208000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9994051456,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca \u043f\u043e\u0434\u0430\u043b\u0430 \u0438\u0441\u043a\u0438 \u043a \u043a\u043e\u043d\u043a\u0443\u0440\u0435\u043d\u0442\u0443 \u0438 \u0421\u041c\u0418 \u043e \u0437\u0430\u0449\u0438\u0442\u0435 \u0434\u0435\u043b\u043e\u0432\u043e\u0439 \u0440\u0435\u043f\u0443\u0442\u0430\u0446\u0438\u0438",
        "description":"\u0421\u0443\u043c\u043c\u0430 \u0442\u0440\u0435\u0431\u043e\u0432\u0430\u043d\u0438\u0439 \u00ab\u0434\u043e\u0447\u043a\u0438\u00bb \u0431\u0440\u0438\u0442\u0430\u043d\u043e-\u0448\u0432\u0435\u0434\u0441\u043a\u043e\u0439 \u0444\u0430\u0440\u043c\u043a\u043e\u043c\u043f\u0430\u043d\u0438\u0438 \u0434\u043e\u0441\u0442\u0438\u0433\u043b\u0430 600 \u043c\u043b\u043d \u0440\u0443\u0431\u043b\u0435\u0439",
        "content":"2024\u00a0. \u00ab\u00bb - AstraZeneca \u00ab \u00bb , , , . , , \u00ab \u00bb, \u00ab \u00bb, \u00ab.ru\u00bb, \u00ab.\u00bb , \u00ab\u00bb ( on-med.ru), \u00ab\u00bb - \u00ab. \u00bb . News Media, - Life.ru ( News Media), Life.ru () . 500 ., 100 ., .",
        "url":"https:\/\/www.vedomosti.ru\/media\/articles\/2024\/09\/19\/1063127-astrazeneca-podala-iski-o-zaschite-delovoi-reputatsii",
        "source":"Vedomosti.ru",
        "published_at":1726696748000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9960158467,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Here\u2019s Why AstraZeneca PLC (AZN) Surged in Q2",
        "description":"Parnassus Investments, an investment management company, released the \u201cParnassus Growth Equity Fund\u201d second quarter 2024 investor letter. A copy of the...",
        "content":"Parnassus Investments, an investment management company, released the Parnassus Growth Equity Fund second quarter 2024 investor letter. A copy of the letter can be downloaded here. In the second quar\u2026 [+2578 chars]",
        "url":"https:\/\/finance.yahoo.com\/news\/why-astrazeneca-plc-azn-surged-124811334.html\/",
        "source":"Yahoo Entertainment",
        "published_at":1727095691000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9556382895,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Several Reasons for the Outperformance of Astrazeneca Plc (AZN)",
        "description":null,
        "content":"If you click 'Accept all', we and our partners, including 239 who are part of the IAB Transparency &amp; Consent Framework, will also store and\/or access information on a device (in other words, use \u2026 [+678 chars]",
        "url":"https:\/\/consent.yahoo.com\/v2\/collectConsent?sessionId=1_cc-session_30b9d19b-4813-4be4-81c2-b7428a3af447",
        "source":"Yahoo Entertainment",
        "published_at":1725340133000,
        "collected_at":1727696449297,
        "sentiment_label":"Negative",
        "sentiment_probabolity":0.5705801845,
        "sentiment_vector":-0.5705801845
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Los resultados de los ensayos de un medicamento para el c\u00e1ncer de pulm\u00f3n golpean a AstraZeneca",
        "description":"Las acciones de AstraZeneca cayeron casi un 5% el martes despu\u00e9s de que su fracaso en la consecuci\u00f3n de un objetivo en los ensayos de un f\u00e1rmaco de nueva generaci\u00f3n contra el...",
        "content":"Pascal Soriot, consejero delegado de AstraZeneca.Cole BurstonEXPANSION\r\nEl fracaso en la consecuci\u00f3n de significancia estad\u00edstica supone un rev\u00e9s para los esfuerzos por construir una cartera oncol\u00f3gi\u2026 [+450 chars]",
        "url":"https:\/\/www.expansion.com\/economia\/financial-times\/2024\/09\/10\/66e04fe6468aeb054a8b4580.html",
        "source":"Expansion.com",
        "published_at":1725977966000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999480247,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Jelent\u0151s \u00e1tt\u00f6r\u00e9st \u00e9rt el a h\u00f3lyagr\u00e1k legy\u0151z\u00e9s\u00e9ben az AstraZeneca gy\u00f3gyszere",
        "description":"Jelent\u0151s \u00e1tt\u00f6r\u00e9st \u00e9rt el a h\u00f3lyagr\u00e1k legy\u0151z\u00e9s\u00e9ben az AstraZeneca gy\u00f3gyszere - Ez az els\u0151 alkalom, hogy egy orvoss\u00e1g ilyen jelent\u0151sen jav\u00edtotta a betegs\u00e9g t\u00fal\u00e9l\u00e9si ar\u00e1ny\u00e1t.",
        "content":"Az izom-invaz\u00edv h\u00f3lyagr\u00e1kban szenved betegekn\u00e9l az Imfinzi 32 sz\u00e1zal\u00e9kkal cs\u00f6kkentette a betegs\u00e9g ki\u00fajul\u00e1s\u00e1nak kock\u00e1zat\u00e1t, amikor a standard kezel\u00e9s mellett adt\u00e1k, \u00e1llap\u00edtotta meg egy k\u00e9si st\u00e1dium\u00fa v\u2026 [+2102 chars]",
        "url":"https:\/\/index.hu\/kulfold\/2024\/09\/16\/astrazeneca-holyagrak-tanulmany\/",
        "source":"Index.hu",
        "published_at":1726496880000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999970198,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca in AI collaboration with Immunai to inform cancer drug trials",
        "description":null,
        "content":"If you click 'Accept all', we and our partners, including 240 who are part of the IAB Transparency &amp; Consent Framework, will also store and\/or access information on a device (in other words, use \u2026 [+678 chars]",
        "url":"https:\/\/consent.yahoo.com\/v2\/collectConsent?sessionId=1_cc-session_097823b0-4420-47e3-bec0-07f14da3fa9f",
        "source":"Yahoo Entertainment",
        "published_at":1727355954000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9997038245,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Could The Market Be Wrong About AstraZeneca PLC (LON:AZN) Given Its Attractive Financial Prospects?",
        "description":"AstraZeneca (LON:AZN) has had a rough month with its share price down 9.1%. But if you pay close attention, you might...",
        "content":"AstraZeneca (LON:AZN) has had a rough month with its share price down 9.1%. But if you pay close attention, you might gather that its strong financials could mean that the stock could potentially see\u2026 [+4652 chars]",
        "url":"https:\/\/finance.yahoo.com\/news\/could-market-wrong-astrazeneca-plc-060040682.html\/",
        "source":"Yahoo Entertainment",
        "published_at":1726725640000,
        "collected_at":1727696449297,
        "sentiment_label":"Positive",
        "sentiment_probabolity":1.0,
        "sentiment_vector":1.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Is AstraZeneca PLC (AZN) the Best Cancer Stock to Buy Now?",
        "description":"We recently compiled a list of the 10 Best Cancer Stocks To Buy Now. In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN...",
        "content":"We recently compiled a list of the 10 Best Cancer Stocks To Buy Now.\u00a0In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) stands against the other cancer stocks.\r\nIn 202\u2026 [+7159 chars]",
        "url":"https:\/\/finance.yahoo.com\/news\/astrazeneca-plc-azn-best-cancer-033228271.html",
        "source":"Yahoo Entertainment",
        "published_at":1725420748000,
        "collected_at":1727696449297,
        "sentiment_label":"Positive",
        "sentiment_probabolity":0.998295486,
        "sentiment_vector":0.998295486
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst",
        "description":"HC Wainwright initiated coverage on Enliven Therapeutics, Inc. (NASDAQ:ELVN) and noted the company as an emerging biotech company developing next-gen...",
        "content":"Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst\r\nHC Wainwright initiated coverage on Enliven Therapeutics, Inc. (NASDAQ:ELVN) and noted \u2026 [+3070 chars]",
        "url":"https:\/\/finance.yahoo.com\/news\/enliven-therapeutics-leukemia-candidate-could-180521661.html",
        "source":"Yahoo Entertainment",
        "published_at":1725905121000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.998600781,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Is AstraZeneca PLC (AZN) the Best Cheap Growth Stock to Buy According to Analysts?",
        "description":"We recently compiled a list of 8 Cheap Growth Stocks to Buy According to Analysts. In this article, we will look at where AstraZeneca PLC (NASDAQ:AZN) ranks ...",
        "content":"We recently compiled a list of 8 Cheap Growth Stocks to Buy According to Analysts. In this article, we will look at where AstraZeneca PLC (NASDAQ:AZN) ranks among the cheap growth stocks to buy accor\u2026 [+6173 chars]",
        "url":"https:\/\/finance.yahoo.com\/news\/astrazeneca-plc-azn-best-cheap-060700768.html\/",
        "source":"Yahoo Entertainment",
        "published_at":1727590020000,
        "collected_at":1727696449297,
        "sentiment_label":"Positive",
        "sentiment_probabolity":0.7359404564,
        "sentiment_vector":0.7359404564
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Is AstraZeneca PLC (AZN) the Best Growth Stock To Buy According To George Soros?",
        "description":null,
        "content":"If you click 'Accept all', we and our partners, including 239 who are part of the IAB Transparency &amp; Consent Framework, will also store and\/or access information on a device (in other words, use \u2026 [+678 chars]",
        "url":"https:\/\/consent.yahoo.com\/v2\/collectConsent?sessionId=1_cc-session_94f1ac5c-11d9-471e-8a83-6e653e8315f9",
        "source":"Yahoo Entertainment",
        "published_at":1727138139000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9988642931,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca PLC (AZN): A Good 52-Week High Stock to Buy According to Short Sellers",
        "description":null,
        "content":"If you click 'Accept all', we and our partners, including 239 who are part of the IAB Transparency &amp; Consent Framework, will also store and\/or access information on a device (in other words, use \u2026 [+678 chars]",
        "url":"https:\/\/consent.yahoo.com\/v2\/collectConsent?sessionId=1_cc-session_e083c589-b543-4615-bc9d-ec5ceaffaac4",
        "source":"Yahoo Entertainment",
        "published_at":1725311245000,
        "collected_at":1727696449297,
        "sentiment_label":"Positive",
        "sentiment_probabolity":0.9999638796,
        "sentiment_vector":0.9999638796
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Woman developed PSYCHOSIS after getting injected with AstraZeneca COVID-19 vaccine",
        "description":"A case study making the rounds on social media outlines how a woman injected with the Wuhan coronavirus (COVID-19) vaccine from AstraZeneca developed psychosis post-vaccination. The case study published January 2022 in Schizophrenia Research touched on an 18-\u2026",
        "content":"A case study making the rounds on social media outlines how a woman injected with the Wuhan coronavirus (COVID-19) vaccine from AstraZeneca developed psychosis post-vaccination.\r\nThe case study publi\u2026 [+4232 chars]",
        "url":"https:\/\/www.naturalnews.com\/2024-09-20-woman-injected-astrazeneca-covid-vaccine-developed-psychosis.html",
        "source":"Naturalnews.com",
        "published_at":1726812000000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.999948144,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca adopte le mod\u00e8le d'IA g\u00e9n\u00e9rative d\u00e9velopp\u00e9 par la start-up Immunai",
        "description":"Avec pour objectif de rendre certains essais de m\u00e9dicaments contre le cancer plus efficaces, AstraZeneca signe un contrat avec une start-up isra\u00e9lienne qui propose une plateforme de cartographie et de reprogrammation du syst\u00e8me immunitaire dop\u00e9e \u00e0 l'IA.",
        "content":"Elle est isra\u00e9lienne, s'est install\u00e9e \u00e0 New York, et est \u00e0 l'origine d'un environnement de d\u00e9veloppement int\u00e9gr\u00e9 (IDE) destin\u00e9 \u00e0 cartographier le syst\u00e8me immunitaire, notamment \u00e0 l'aide de l'intellig\u2026 [+3881 chars]",
        "url":"https:\/\/www.usine-digitale.fr\/article\/astrazeneca-adopte-le-modele-d-ia-generative-developpe-par-la-start-up-immunai.N2219405",
        "source":"Usine-digitale.fr",
        "published_at":1727439840000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999872446,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"\u0412 \u041a\u0438\u0442\u0430\u0435 \u0437\u0430\u0434\u0435\u0440\u0436\u0430\u043d\u044b \u0441\u043e\u0442\u0440\u0443\u0434\u043d\u0438\u043a\u0438 AstraZeneca \u043f\u043e \u0434\u0435\u043b\u0443 \u043e \u043d\u0435\u0437\u0430\u043a\u043e\u043d\u043d\u043e\u0439 \u0434\u0435\u044f\u0442\u0435\u043b\u044c\u043d\u043e\u0441\u0442\u0438",
        "description":"\u041f\u043e\u043b\u0438\u0446\u0438\u044f \u041a\u0438\u0442\u0430\u044f \u0437\u0430\u0434\u0435\u0440\u0436\u0430\u043b\u0430 \u043f\u044f\u0442\u0435\u0440\u044b\u0445 \u0434\u0435\u0439\u0441\u0442\u0432\u0443\u044e\u0449\u0438\u0445 \u0438 \u0431\u044b\u0432\u0448\u0438\u0445 \u0441\u043e\u0442\u0440\u0443\u0434\u043d\u0438\u043a\u043e\u0432 \u0431\u0440\u0438\u0442\u0430\u043d\u0441\u043a\u043e\u0439 \u0444\u0430\u0440\u043c\u0430\u0446\u0435\u0432\u0442\u0438\u0447\u0435\u0441\u043a\u043e\u0439 \u043a\u043e\u043c\u043f\u0430\u043d\u0438\u0438 AstraZeneca, \u043f\u0440\u043e\u0438\u0437\u0432\u043e\u0434\u0438\u0442\u0435\u043b\u044f \u0432\u0430\u043a\u0446\u0438\u043d \u043e\u0442 COVID-19, \u0434\u043b\u044f \u0434\u043e\u043f\u0440\u043e\u0441\u0430 \u043e \u0432\u043e\u0437\u043c\u043e\u0436\u043d\u043e\u0439 \u043d\u0435\u0437\u0430\u043a\u043e\u043d\u043d\u043e\u0439 \u0434\u0435\u044f\u0442\u0435\u043b\u044c\u043d\u043e\u0441\u0442\u0438. \u041e\u0431 \u044d\u0442\u043e\u043c \u0441\u043e\u043e\u0431\u0449\u0430\u0435\u0442 Bloomberg \u0441\u043e \u0441\u0441\u044b\u043b\u043a\u043e\u0439 \u043d\u0430 \u043d\u0435\u0441\u043a\u043e\u043b\u044c\u043a\u043e \u043e\u0441\u0432\u0435\u0434\u043e\u043c\u043b\u0435\u043d\u2026",
        "content":", AstraZeneca, . , . , , , . , , .\r\n, . , AstraZeneca Imjudo. , 200 (28 ) , , .\r\nAstraZeneca 1993 5,9 , 10 .",
        "url":"https:\/\/rg.ru\/2024\/09\/05\/v-kitae-zaderzhany-sotrudniki-astrazeneca-po-delu-o-nezakonnoj-deiatelnosti.html",
        "source":"Rg.ru",
        "published_at":1725522817000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999119043,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Ac\u0163iunile AstraZeneca scad dup\u0103 e\u015fecul studiului unui medicament \u00eempotriva cancerului pulmonar",
        "description":"Ac\u0163iunile AstraZeneca, listate la Londra, au sc\u0103zut mar\u0163i cu peste 5%, dup\u0103 ce rezultatele studiilor companiei privind cancerul pulmonar au ar\u0103tat c\u0103 medicamentul s\u0103u experimental de precizie nu a \u00eembun\u0103t\u0103\u0163it semnificativ rezultatele globale de supravie\u0163uire \u2026",
        "content":"Aciunile au sczut cu p\u00e2n la 5,6% la 119,98 lire sterline \u00een tranzaciile de diminea, aciunile, care au crescut cu aproape 18% \u00een acest an, fiind pregtite pentru cea mai mare scdere de o zi din ultimel\u2026 [+1477 chars]",
        "url":"https:\/\/www.mediafax.ro\/economic\/actiunile-astrazeneca-scad-dupa-esecul-studiului-unui-medicament-impotriva-cancerului-pulmonar-22483356",
        "source":"Mediafax.ro",
        "published_at":1726029858000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999949932,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Fact Check. Vacina contra a Covid-19 da Astrazeneca \u00e9 respons\u00e1vel pela transmiss\u00e3o da Mpox?",
        "description":"Publica\u00e7\u00f5es no Facebook relacionam a transmiss\u00e3o da var\u00edola dos macacos com a vacina da Astrazeneca, que tem na sua composi\u00e7\u00e3o adenov\u00edrus de chimpanz\u00e9. Mas n\u00e3o existe qualquer rela\u00e7\u00e3o.",
        "content":"Depois do ressurgimento da var\u00edola dos macacos no palco medi\u00e1tico, em agosto (devido a uma nova variante mais transmiss\u00edvel), come\u00e7aram a circular nas redes sociais as habituais teorias envolvendo a \u2026 [+3521 chars]",
        "url":"https:\/\/observador.pt\/factchecks\/fact-check-vacina-contra-a-covid-19-da-astrazeneca-e-responsavel-pela-transmissao-da-mpox\/",
        "source":"Observador.pt",
        "published_at":1727282164000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999904633,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca in AI collaboration with Immunai to inform cancer drug trials",
        "description":"AstraZeneca will pay $18 million to biotechnology firm Immunai Inc to use the New York-based firm's AI model of the immune system to make certain cancer drug trials more efficient, the latter said on Thursday.This is the latest in a string of tie-ups by Anglo\u2026",
        "content":"AstraZeneca will pay $18 million to biotechnology firm Immunai Inc to use the New York-based firm's AI model of the immune system to make certain cancer drug trials more efficient, the latter said on\u2026 [+982 chars]",
        "url":"https:\/\/www.channelnewsasia.com\/business\/astrazeneca-ai-collaboration-immunai-inform-cancer-drug-trials-4640211",
        "source":"CNA",
        "published_at":1727355954000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999824762,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"\u00c1tt\u00f6r\u00e9sr\u0151l jelentett a r\u00e1kkutat\u00e1sban az AstraZeneca",
        "description":"Az AstraZeneca \u00e1ltal kifejlesztett Imfinzi nev\u0171 gy\u00f3gyszer jelent\u0151s \u00e1tt\u00f6r\u00e9st hozott a hugyh\u00f3lyagr\u00e1k kezel\u00e9s\u00e9ben. Egy k\u00e9s\u0151i st\u00e1dium\u00fa vizsg\u00e1lat id\u0151k\u00f6zi elemz\u00e9se szerint az Imfinzi 32%-kal cs\u00f6kkentette a betegs\u00e9g ki\u00fajul\u00e1s\u00e1nak kock\u00e1zat\u00e1t izom-invaz\u00edv h\u00f3lyagr\u00e1kban \u2026",
        "content":"A 1063 beteg bevon\u00e1s\u00e1val v\u00e9gzett kutat\u00e1s azt is kimutatta, hogy a gy\u00f3gyszer 25%-kal cs\u00f6kkentette a hal\u00e1loz\u00e1s kock\u00e1zat\u00e1t, amikor a hagyom\u00e1nyos kezel\u00e9sekhez, p\u00e9ld\u00e1ul kemoter\u00e1pi\u00e1hoz \u00e9s mt\u00e9thez adt\u00e1k hoz\u2026 [+1067 chars]",
        "url":"https:\/\/www.portfolio.hu\/global\/20240915\/attoresrol-jelentett-a-rakkutatasban-az-astrazeneca-709929",
        "source":"Portfolio.hu",
        "published_at":1726420800000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999973774,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca says staff detained in China amid reports of a drug-import investigation",
        "description":"Some employees of British pharmaceutical giant AstraZeneca have been detained by police in China as part of an investigation, the company confirmed Thursday.",
        "content":"Some employees of British pharmaceutical giant AstraZeneca have been detained by police in China as part of an investigation, the company confirmed Thursday.\r\n\"We are aware a small number of our empl\u2026 [+1287 chars]",
        "url":"https:\/\/www.cnbc.com\/2024\/09\/05\/astrazeneca-staff-detained-in-china-amid-reported-drug-import-probe.html",
        "source":"CNBC",
        "published_at":1725535620000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9851743579,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca usar\u00e1 IA para tomar mejores decisiones en pruebas cl\u00ednicas con un objetivo: mejorar la medicina contra el c\u00e1ncer",
        "description":"Hay unas aplicaciones de la inteligencia artificial que son divertidas, otras muy controvertidas y, definitivamente, algunas que podr\u00edan cambiar para bien el camino de la humanidad.\n<!-- BREAK 1 -->\nEsta \u00faltima es el caso de la colaboraci\u00f3n entre el laborator\u2026",
        "content":"Hay unas aplicaciones de la inteligencia artificial que son divertidas, otras muy controvertidas y, definitivamente, algunas que podr\u00edan cambiar para bien el camino de la humanidad.\r\nEsta \u00faltima es e\u2026 [+3470 chars]",
        "url":"https:\/\/www.xataka.com.mx\/medicina-y-salud\/astrazeneca-usara-ia-para-tomar-mejores-decisiones-pruebas-clinicas-objetivo-mejorar-medicina-cancer",
        "source":"Xataka.com.mx",
        "published_at":1727456499000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999736547,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca Employees Held in China for Data Privacy, Drug-Import Investigations",
        "description":"Five current and former AstraZeneca employees reportedly have been detained by police in China in connection with alleged violations of data privacy laws and importing an unapproved cancer drug.",
        "content":"<ul><li>Five current and former AstraZeneca employees have reportedly been detained in China in connection with a pair of investigations.<\/li><li>The investigations concern the importation of an unap\u2026 [+1057 chars]",
        "url":"https:\/\/www.investopedia.com\/astrazeneca-employees-held-in-china-for-drug-import-data-privacy-investigations-8707058",
        "source":"Investopedia",
        "published_at":1725562619000,
        "collected_at":1727696449297,
        "sentiment_label":"Negative",
        "sentiment_probabolity":0.9963700771,
        "sentiment_vector":-0.9963700771
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Covid, nel 2021 Boris Johnson prepar\u00f2 un \"raid\" per sequestrare all'Olanda i vaccini Astrazeneca",
        "description":"Un piano, definito da lui stesso \"folle\", era stato messo in atto dall'ex primo ministro inglese Boris Johnson per riprendersi dall'Olanda dosi di vaccino Astrazeneca con un raid delle forze armate",
        "content":"Ancora oggi, a quasi cinque anni di distanza dalla rivoluzione portata dal Covid, continuano aduscire notizie su quel periodoche fanno riflettere su quanto il mondo stesse vivendo situazioni che, vis\u2026 [+2075 chars]",
        "url":"https:\/\/www.ilgiornale.it\/news\/difesa\/covid-nel-2021-boris-johnson-preparava-raid-acquatico-2374203.html",
        "source":"Ilgiornale.it",
        "published_at":1727538935000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999895096,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Immunai, AstraZeneca collaborate to optimize cancer clinical trials",
        "description":"Under the terms of the agreement, AstraZeneca will leverage Immunai\u2019s platform and machine learning capabilities to inform certain oncology clinical trials.",
        "content":"Immunai Inc., a New York-based artificial intelligence and biotech company specializing in mapping the human immune system, has announced a multi-year collaboration with pharmaceutical giant AstraZen\u2026 [+2634 chars]",
        "url":"https:\/\/www.jpost.com\/health-and-wellness\/article-821909",
        "source":"The Jerusalem Post",
        "published_at":1727358068000,
        "collected_at":1727696449297,
        "sentiment_label":"Positive",
        "sentiment_probabolity":0.9794064164,
        "sentiment_vector":0.9794064164
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Mai mul\u0163i angaja\u0163i ai gigantului farmaceutic AstraZeneca au fost aresta\u021bi \u00een cadrul unei anchete \u00een China",
        "description":"Mai mul\u0163i angaja\u0163i ai AstraZeneca sunt viza\u0163i de o anchet\u0103 \u00een China, a indicat joi pentru AFP gigantul farmaceutic britanic. Investiga\u0163iile, potrivit agen\u0163iei Bloomberg, privesc posibile colect\u0103ri de date \u015fi importuri ilegale de medicamente.",
        "content":"Mai muli angajai ai AstraZeneca sunt vizai de o anchet \u00een China, a indicat joi pentru AFP gigantul farmaceutic britanic. Investigaiile, potrivit ageniei Bloomberg, privesc posibile colectri de date i\u2026 [+1440 chars]",
        "url":"https:\/\/www.digi24.ro\/stiri\/externe\/mapamond\/mai-multi-angajati-ai-gigantului-farmaceutic-astrazeneca-au-fost-arestati-in-cadrul-unei-anchete-in-china-2919193",
        "source":"Digi24.ro",
        "published_at":1725545195000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999930859,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca colabora con Immunai para utilizar la IA en ensayos de f\u00e1rmacos contra el c\u00e1ncer",
        "description":"Forbes M\u00e9xico.\n AstraZeneca colabora con Immunai para utilizar la IA en ensayos de f\u00e1rmacos contra el c\u00e1ncer\n\nEste es el \u00faltimo de una serie de acuerdos de AstraZeneca para utilizar inteligencia artificial para el descubrimiento y desarrollo de f\u00e1rmacos.\nAstr\u2026",
        "content":"AstraZeneca pagar\u00e1 18 millones de d\u00f3lares a la empresa de biotecnolog\u00eda Immunai Inc para utilizar el modelo de inteligencia artificial del sistema inmunol\u00f3gico de la empresa con sede en Nueva York pa\u2026 [+1483 chars]",
        "url":"https:\/\/www.forbes.com.mx\/astrazeneca-colabora-con-immunai-para-utilizar-la-ia-en-ensayos-de-farmacos-contra-el-cancer\/",
        "source":"Forbes.com.mx",
        "published_at":1727362297000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999725819,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca (OTCMKTS:AZNCF) Shares Down 1.6%",
        "description":"AstraZeneca PLC (OTCMKTS:AZNCF \u2013 Get Free Report)\u2019s stock price was down 1.6% during trading on Friday . The company traded as low as $155.14 and last traded at $155.14. Approximately 849 shares were traded during mid-day trading, a decline of 70% from the av\u2026",
        "content":"AstraZeneca PLC (OTCMKTS:AZNCF \u2013 Get Free Report)\u2019s stock price was down 1.6% during trading on Friday . The company traded as low as $155.14 and last traded at $155.14. Approximately 849 shares were\u2026 [+1929 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/21\/astrazeneca-otcmktsazncf-shares-down-1-6\/",
        "source":"ETF Daily News",
        "published_at":1726897744000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9572738409,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Vaccino AstraZeneca, dubbi sull\u2019efficacia per gli over 65",
        "description":"Vaccino AstraZeneca: l'efficacia per gli over 65 \u00e8 stata messa in dubbio dai media tedeschi. L'Ema sta valutando il da farsi",
        "content":"Vaccino AstraZeneca: l'efficacia per gli over 65 \u00e8 stata messa in dubbio dai media tedeschi. L'Ema sta valutando il da farsi Sul vaccino AstraZeneca e sulla sua efficacia per le persone over 65 si at\u2026 [+2146 chars]",
        "url":"https:\/\/www.benessereblog.it\/vaccino-astrazeneca-dubbi-efficacia-over-65",
        "source":"Benessereblog.it",
        "published_at":1726999353000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999923706,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"European shares hold ground as AstraZeneca drags, tech shares rise",
        "description":"AstraZeneca was the biggest drag, sliding 5% after detailed study results showed its experimental lung cancer drug did not significantly improve patients' overall survival results.",
        "content":"(What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2024 and expert advice, on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets\u2026 [+317 chars]",
        "url":"https:\/\/economictimes.indiatimes.com\/markets\/stocks\/news\/european-shares-hold-ground-as-astrazeneca-drags-tech-shares-rise\/articleshow\/113221245.cms",
        "source":"The Times of India",
        "published_at":1725956418000,
        "collected_at":1727696449297,
        "sentiment_label":"Positive",
        "sentiment_probabolity":0.9999985695,
        "sentiment_vector":0.9999985695
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca Sees Unusually Large Options Volume (NASDAQ:AZN)",
        "description":"AstraZeneca PLC (NASDAQ:AZN \u2013 Get Free Report) saw some unusual options trading activity on Monday. Traders acquired 16,356 put options on the stock. This represents an increase of approximately 137% compared to the typical volume of 6,894 put options. AstraZ\u2026",
        "content":"AstraZeneca PLC (NASDAQ:AZN \u2013 Get Free Report) saw some unusual options trading activity on Monday. Traders acquired 16,356 put options on the stock. This represents an increase of approximately 137%\u2026 [+4919 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/11\/astrazeneca-sees-unusually-large-options-volume-nasdaqazn\/",
        "source":"ETF Daily News",
        "published_at":1726031932000,
        "collected_at":1727696449297,
        "sentiment_label":"Positive",
        "sentiment_probabolity":0.9906049371,
        "sentiment_vector":0.9906049371
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca maintains Buy rating despite TL01 risks",
        "description":"AstraZeneca maintains Buy rating despite TL01 risks",
        "content":"On Monday, BofA Securities maintained its Buy rating and $91.70 price target for AstraZeneca (NASDAQ:AZN) shares, despite potential approval risks for the company's datopotamab deruxtecan (TL01) trea\u2026 [+5000 chars]",
        "url":"https:\/\/www.investing.com\/news\/company-news\/astrazeneca-maintains-buy-rating-despite-tl01-risks-93CH-3608006",
        "source":"Investing.com",
        "published_at":1725910530000,
        "collected_at":1727696449297,
        "sentiment_label":"Positive",
        "sentiment_probabolity":1.0,
        "sentiment_vector":1.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca PLC (NASDAQ:AZN) Short Interest Update",
        "description":"AstraZeneca PLC (NASDAQ:AZN - Get Free Report) was the target of a significant decline in short interest in September. As of September 15th, there was short interest totalling 6,450,000 shares, a decline of 27.2% from the August 31st total of 8,860,000 shares\u2026",
        "content":"AstraZeneca PLC (NASDAQ:AZN - Get Free Report) was the target of a significant decline in short interest in September. As of September 15th, there was short interest totalling 6,450,000 shares, a dec\u2026 [+138 chars]",
        "url":"https:\/\/biztoc.com\/x\/f34259598620382a",
        "source":"Biztoc.com",
        "published_at":1727550442000,
        "collected_at":1727696449297,
        "sentiment_label":"Negative",
        "sentiment_probabolity":0.9957488179,
        "sentiment_vector":-0.9957488179
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Sophia Genetics announces collaboration agreement with AstraZeneca",
        "description":"See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor\u2026",
        "content":"Earnings calls, analyst events, roadshows and more",
        "url":"https:\/\/thefly.com\/permalinks\/entry.php\/id3981323\/SOPH;AZN-Sophia-Genetics-announces-collaboration-agreement-with-AstraZeneca",
        "source":"Thefly.com",
        "published_at":1725978061000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9950527549,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca chair buys 2,000 company shares",
        "description":"AstraZeneca chair buys 2,000 company shares",
        "content":"AstraZeneca PLC (LSE:LON:AZN) announced today that Michel Demar\u00e9, the Non-Executive Chair of the Board, has purchased 2,000 ordinary shares of the company at a price of \u00a3117.927465 per share. The tra\u2026 [+3998 chars]",
        "url":"https:\/\/www.investing.com\/news\/company-news\/astrazeneca-chair-buys-2000-company-shares-93CH-3615770",
        "source":"Investing.com",
        "published_at":1726239594000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9822674394,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca reports total voting rights as of August end",
        "description":"AstraZeneca reports total voting rights as of August end",
        "content":"AstraZeneca PLC (LSE:LON:AZN), the global biopharmaceutical company, announced on Monday that as of August 31, 2024, its issued share capital comprised 1,550,286,637 ordinary shares with voting right\u2026 [+4153 chars]",
        "url":"https:\/\/www.investing.com\/news\/company-news\/astrazeneca-reports-total-voting-rights-as-of-august-end-93CH-3598388",
        "source":"Investing.com",
        "published_at":1725373056000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999967813,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Advisor OS LLC Boosts Stake in AstraZeneca PLC (NASDAQ:AZN)",
        "description":"Advisor OS LLC increased its position in AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 4.2% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 5,617 shares of the company\u2019s stock after purchasing an additional 226 shares duri\u2026",
        "content":"Advisor OS LLC increased its position in AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 4.2% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 5,617 shares of the co\u2026 [+4810 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/08\/advisor-os-llc-boosts-stake-in-astrazeneca-plc-nasdaqazn\/",
        "source":"ETF Daily News",
        "published_at":1725797812000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.7574442029,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Banque Cantonale Vaudoise Raises Holdings in AstraZeneca PLC (NASDAQ:AZN)",
        "description":"Banque Cantonale Vaudoise increased its position in shares of AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 78.7% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,269 \u2026",
        "content":"Banque Cantonale Vaudoise increased its position in shares of AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 78.7% during the 2nd quarter, according to the company in its most recent disclosure with t\u2026 [+4832 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/04\/banque-cantonale-vaudoise-raises-holdings-in-astrazeneca-plc-nasdaqazn\/",
        "source":"ETF Daily News",
        "published_at":1725444925000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9985160232,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca shares down on disappointing drug trial results",
        "description":"AstraZeneca shares down on disappointing drug trial results",
        "content":"Investing.com -- Shares of AstraZeneca (LON:AZN) dropped on Thursday following the presentation of disappointing final overall survival data from the TROPION-Lung-01 (TL-01) trial at the World Confer\u2026 [+3168 chars]",
        "url":"https:\/\/www.investing.com\/news\/stock-market-news\/astrazeneca-shares-down-on-disappointing-drug-trial-results-3608752",
        "source":"Investing.com",
        "published_at":1725959324000,
        "collected_at":1727696449297,
        "sentiment_label":"Negative",
        "sentiment_probabolity":0.9999996424,
        "sentiment_vector":-0.9999996424
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"European shares hold ground as AstraZeneca drags, tech shares rise",
        "description":"European shares hold ground as AstraZeneca drags, tech shares rise",
        "content":"(Reuters) - European shares were flat on Tuesday, after a 1% jump in the previous session, as investors parsed through a mixed set of economic data while awaiting a widely expected ECB rate cut later\u2026 [+912 chars]",
        "url":"https:\/\/www.investing.com\/news\/stock-market-news\/european-shares-hold-ground-as-astrazeneca-drags-tech-shares-rise-3608650",
        "source":"Investing.com",
        "published_at":1725953796000,
        "collected_at":1727696449297,
        "sentiment_label":"Positive",
        "sentiment_probabolity":0.7165170908,
        "sentiment_vector":0.7165170908
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca (NASDAQ:AZN) Cut to \u201cSell\u201d at Deutsche Bank Aktiengesellschaft",
        "description":"Deutsche Bank Aktiengesellschaft downgraded shares of AstraZeneca (NASDAQ:AZN \u2013 Free Report) from a hold rating to a sell rating in a research report sent to investors on Friday morning, MarketBeat reports. Other equities analysts also recently issued reports\u2026",
        "content":"Deutsche Bank Aktiengesellschaft downgraded shares of AstraZeneca (NASDAQ:AZN \u2013 Free Report) from a hold rating to a sell rating in a research report sent to investors on Friday morning, MarketBeat r\u2026 [+4517 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/16\/astrazeneca-nasdaqazn-cut-to-sell-at-deutsche-bank-aktiengesellschaft\/",
        "source":"ETF Daily News",
        "published_at":1726464173000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9987811446,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Deutsche Bank downgrades AstraZeneca stock as key oncology asset disappoints",
        "description":"Deutsche Bank downgrades AstraZeneca stock as key oncology asset disappoints",
        "content":"On Friday, Deutsche Bank issued a downgrade for AstraZeneca (NASDAQ:AZN) stock from Hold to Sell, adjusting the price target to \u00a3105.00 from the previous \u00a3110.00. The firm cited concerns over the pha\u2026 [+4138 chars]",
        "url":"https:\/\/www.investing.com\/news\/company-news\/deutsche-bank-downgrades-astrazeneca-stock-as-key-oncology-asset-disappoints-93CH-3614835",
        "source":"Investing.com",
        "published_at":1726216183000,
        "collected_at":1727696449297,
        "sentiment_label":"Negative",
        "sentiment_probabolity":0.9999965429,
        "sentiment_vector":-0.9999965429
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca PLC (NASDAQ:AZN) Shares Purchased by Bank of Montreal Can",
        "description":"Bank of Montreal Can increased its stake in AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 35.5% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,465,575 shares of the company\u2019s stock after acquiring an additi\u2026",
        "content":"Bank of Montreal Can increased its stake in AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 35.5% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,465\u2026 [+5057 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/24\/astrazeneca-plc-nasdaqazn-shares-purchased-by-bank-of-montreal-can\/",
        "source":"ETF Daily News",
        "published_at":1727189071000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999779463,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Gabelli Funds LLC Lowers Stake in AstraZeneca PLC (NASDAQ:AZN)",
        "description":"Gabelli Funds LLC lessened its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 17.9% during the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 73,200 shares of the company's stock after selling 15\u2026",
        "content":"Gabelli Funds LLC lessened its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 17.9% during the second quarter, according to the company in its most recent disclosure with the SEC. The firm\u2026 [+133 chars]",
        "url":"https:\/\/biztoc.com\/x\/182c36d882421eb7",
        "source":"Biztoc.com",
        "published_at":1727256977000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9994707704,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca PLC (NASDAQ:AZN) Holdings Lifted by Edge Capital Group LLC",
        "description":"Edge Capital Group LLC increased its holdings in AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 2.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 144,30\u2026",
        "content":"Edge Capital Group LLC increased its holdings in AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 2.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and \u2026 [+5153 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/22\/astrazeneca-plc-nasdaqazn-holdings-lifted-by-edge-capital-group-llc\/",
        "source":"ETF Daily News",
        "published_at":1727016640000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999673367,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca drug fails to extend lives of breast cancer patients",
        "description":"AstraZeneca drug fails to extend lives of breast cancer patients Financial Times\nAstraZeneca, Daiichi\u2019s Trodelvy rival fails to improve overall survival in breast cancer trial Fierce Biotech\nAstraZeneca and Daiichi Suffer New Setback With Mixed Breast Cancer \u2026",
        "content":"AstraZeneca drug fails to extend lives of breast cancer patients Financial TimesAstraZeneca, Daiichis Trodelvy rival fails to improve overall survival in breast cancer trial Fierce BiotechAstraZeneca\u2026 [+121 chars]",
        "url":"https:\/\/biztoc.com\/x\/39de23e3544451b1",
        "source":"Biztoc.com",
        "published_at":1727100947000,
        "collected_at":1727696449297,
        "sentiment_label":"Negative",
        "sentiment_probabolity":0.9836956263,
        "sentiment_vector":-0.9836956263
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca PLC (NASDAQ:AZN) Stock Position Raised by Sei Investments Co.",
        "description":"Sei Investments Co. raised its stake in AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 9.8% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 879,446 shares of the company\u2019s \u2026",
        "content":"Sei Investments Co. raised its stake in AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 9.8% in the second quarter, according to the company in its most recent disclosure with the Securities &amp; Exch\u2026 [+5059 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/22\/astrazeneca-plc-nasdaqazn-stock-position-raised-by-sei-investments-co\/",
        "source":"ETF Daily News",
        "published_at":1727018945000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999911785,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca PLC (NASDAQ:AZN) Shares Sold by Marathon Capital Management",
        "description":"Marathon Capital Management lessened its position in AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 0.1% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1\u2026",
        "content":"Marathon Capital Management lessened its position in AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 0.1% in the second quarter, according to the company in its most recent 13F filing with the Securiti\u2026 [+5297 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/28\/astrazeneca-plc-nasdaqazn-shares-sold-by-marathon-capital-management\/",
        "source":"ETF Daily News",
        "published_at":1727505094000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9974610806,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca and MSD hail progress in hard-to-treat cancers",
        "description":"Results offer hope of progress in tackling bladder tumours and some forms of breast cancer",
        "content":"Results offer hope of progress in tackling bladder tumours and some forms of breast cancer\r\nThis story appeared on ft.com, 2024-09-17.",
        "url":"https:\/\/biztoc.com\/x\/14548124d0dd7ed1",
        "source":"Biztoc.com",
        "published_at":1726546679000,
        "collected_at":1727696449297,
        "sentiment_label":"Positive",
        "sentiment_probabolity":0.9999051094,
        "sentiment_vector":0.9999051094
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Insider Buying: AstraZeneca PLC (LON:AZN) Insider Buys \u00a32,360 in Stock",
        "description":"AstraZeneca PLC (LON:AZN \u2013 Get Free Report) insider Michel Demare acquired 2,000 shares of the business\u2019s stock in a transaction on Friday, September 13th. The stock was purchased at an average price of GBX 118 ($1.56) per share, for a total transaction of \u00a32\u2026",
        "content":"AstraZeneca PLC (LON:AZN \u2013 Get Free Report) insider Michel Demare acquired 2,000 shares of the business\u2019s stock in a transaction on Friday, September 13th. The stock was purchased at an average price\u2026 [+2870 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/17\/insider-buying-astrazeneca-plc-lonazn-insider-buys-2360-in-stock\/",
        "source":"ETF Daily News",
        "published_at":1726554324000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.999963522,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Clayton Partners LLC Buys 9,668 Shares of AstraZeneca PLC (NASDAQ:AZN)",
        "description":"Clayton Partners LLC boosted its position in shares of AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 26.2% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 46,542 shares of the company\u2019s stock after pu\u2026",
        "content":"Clayton Partners LLC boosted its position in shares of AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 26.2% in the second quarter, according to the company in its most recent disclosure with the SEC. \u2026 [+5449 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/21\/clayton-partners-llc-buys-9668-shares-of-astrazeneca-plc-nasdaqazn\/",
        "source":"ETF Daily News",
        "published_at":1726934685000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999939203,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Brokerages Set AstraZeneca PLC (NASDAQ:AZN) Price Target at $89.75",
        "description":"Shares of AstraZeneca PLC (NASDAQ:AZN \u2013 Get Free Report) have been given an average recommendation of \u201cModerate Buy\u201d by the eleven analysts that are covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommend\u2026",
        "content":"Shares of AstraZeneca PLC (NASDAQ:AZN \u2013 Get Free Report) have been given an average recommendation of \u201cModerate Buy\u201d by the eleven analysts that are covering the stock, Marketbeat Ratings reports. On\u2026 [+4634 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/21\/brokerages-set-astrazeneca-plc-nasdaqazn-price-target-at-89-75\/",
        "source":"ETF Daily News",
        "published_at":1726896407000,
        "collected_at":1727696449297,
        "sentiment_label":"Positive",
        "sentiment_probabolity":0.7956570983,
        "sentiment_vector":0.7956570983
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Arkadios Wealth Advisors Raises Position in AstraZeneca PLC (NASDAQ:AZN)",
        "description":"Arkadios Wealth Advisors lifted its stake in shares of AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 11.2% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,642 shares of the compa\u2026",
        "content":"Arkadios Wealth Advisors lifted its stake in shares of AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 11.2% during the second quarter, according to its most recent disclosure with the Securities and E\u2026 [+5244 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/08\/31\/arkadios-wealth-advisors-raises-position-in-astrazeneca-plc-nasdaqazn\/",
        "source":"ETF Daily News",
        "published_at":1725107574000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999597073,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Five AstraZeneca employees under investigation in China, Bloomberg reports",
        "description":"See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor\u2026",
        "content":"Earnings calls, analyst events, roadshows and more",
        "url":"https:\/\/thefly.com\/permalinks\/entry.php\/id3978755\/AZN-Five-AstraZeneca-employees-under-investigation-in-China-Bloomberg-reports",
        "source":"Thefly.com",
        "published_at":1725529636000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999358654,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca PLC (NASDAQ:AZN) Shares Purchased by Drive Wealth Management LLC",
        "description":"Drive Wealth Management LLC raised its holdings in AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 10.4% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 4,232 shares of the company\u2019s stock after acquiri\u2026",
        "content":"Drive Wealth Management LLC raised its holdings in AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 10.4% in the second quarter, according to the company in its most recent disclosure with the SEC. The \u2026 [+4579 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/02\/astrazeneca-plc-nasdaqazn-shares-purchased-by-drive-wealth-management-llc\/",
        "source":"ETF Daily News",
        "published_at":1725293450000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999893904,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Zacks Research Weighs in on AstraZeneca PLC\u2019s FY2025 Earnings (NASDAQ:AZN)",
        "description":"AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) \u2013 Equities research analysts at Zacks Research upped their FY2025 earnings estimates for shares of AstraZeneca in a research note issued to investors on Wednesday, August 28th. Zacks Research analyst R. Department no\u2026",
        "content":"AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) \u2013 Equities research analysts at Zacks Research upped their FY2025 earnings estimates for shares of AstraZeneca in a research note issued to investors on Wed\u2026 [+4697 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/02\/zacks-research-weighs-in-on-astrazeneca-plcs-fy2025-earnings-nasdaqazn\/",
        "source":"ETF Daily News",
        "published_at":1725257452000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999940395,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca (NASDAQ:AZN) Upgraded to Buy at Erste Group Bank",
        "description":"AstraZeneca (NASDAQ:AZN \u2013 Get Free Report) was upgraded by Erste Group Bank from a \u201chold\u201d rating to a \u201cbuy\u201d rating in a report issued on Wednesday, Benzinga reports. A number of other research analysts have also recently issued reports on AZN. Citigroup upgra\u2026",
        "content":"AstraZeneca (NASDAQ:AZN \u2013 Get Free Report) was upgraded by Erste Group Bank from a \u201chold\u201d rating to a \u201cbuy\u201d rating in a report issued on Wednesday, Benzinga reports.\r\nA number of other research analy\u2026 [+4219 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/13\/astrazeneca-nasdaqazn-upgraded-to-buy-at-erste-group-bank\/",
        "source":"ETF Daily News",
        "published_at":1726209058000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.8741942644,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca Dips On Surprise Miss For Gilead-Rivaling Cancer Drug",
        "description":"AstraZeneca stock slumped Monday after its Daiichi Sankyo-partnered drug missed its mark in a study of patients with breast cancer.\nThe post AstraZeneca Dips On Surprise Miss For Gilead-Rivaling Cancer Drug appeared first on Investor's Business Daily.",
        "content":"AstraZeneca stock slumped Monday after its Daiichi Sankyo-partnered drug missed its mark in a study of patients with breast cancer.The post AstraZeneca Dips On Surprise Miss For Gilead-Rivaling Cance\u2026 [+101 chars]",
        "url":"https:\/\/biztoc.com\/x\/a2cb767c7662f1c6",
        "source":"Biztoc.com",
        "published_at":1727100245000,
        "collected_at":1727696449297,
        "sentiment_label":"Negative",
        "sentiment_probabolity":0.9999263287,
        "sentiment_vector":-0.9999263287
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca PLC (NASDAQ:AZN) Shares Sold by Marshall Wace LLP",
        "description":"Marshall Wace LLP cut its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 48.7% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor own\u2026",
        "content":"Marshall Wace LLP cut its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 48.7% in the second quarter, according to the company in its most recent disclosure with the Securities a\u2026 [+135 chars]",
        "url":"https:\/\/biztoc.com\/x\/3a953566727cfb91",
        "source":"Biztoc.com",
        "published_at":1727342888000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.999964118,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"American Century Companies Inc. Lowers Position in AstraZeneca PLC (NASDAQ:AZN)",
        "description":"American Century Companies Inc. lessened its holdings in shares of AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 38.6% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 52\u2026",
        "content":"American Century Companies Inc. lessened its holdings in shares of AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 38.6% in the second quarter, according to the company in its most recent 13F filing wi\u2026 [+4962 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/18\/american-century-companies-inc-lowers-position-in-astrazeneca-plc-nasdaqazn\/",
        "source":"ETF Daily News",
        "published_at":1726654250000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9997138381,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Head-To-Head Analysis: Regeneron Pharmaceuticals (NASDAQ:REGN) & AstraZeneca (NASDAQ:AZN)",
        "description":"Regeneron Pharmaceuticals (NASDAQ:REGN \u2013 Get Free Report) and AstraZeneca (NASDAQ:AZN \u2013 Get Free Report) are both large-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability\u2026",
        "content":"Regeneron Pharmaceuticals (NASDAQ:REGN \u2013 Get Free Report) and AstraZeneca (NASDAQ:AZN \u2013 Get Free Report) are both large-cap medical companies, but which is the superior investment? We will compare th\u2026 [+6094 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/24\/head-to-head-analysis-regeneron-pharmaceuticals-nasdaqregn-astrazeneca-nasdaqazn\/",
        "source":"ETF Daily News",
        "published_at":1727182510000,
        "collected_at":1727696449297,
        "sentiment_label":"Positive",
        "sentiment_probabolity":0.9999998808,
        "sentiment_vector":0.9999998808
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"DRW Securities LLC Purchases New Position in AstraZeneca PLC (NASDAQ:AZN)",
        "description":"DRW Securities LLC acquired a new stake in shares of AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 25,009 shares of the co\u2026",
        "content":"DRW Securities LLC acquired a new stake in shares of AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities &amp\u2026 [+5036 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/22\/drw-securities-llc-purchases-new-position-in-astrazeneca-plc-nasdaqazn\/",
        "source":"ETF Daily News",
        "published_at":1727014806000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999614954,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca (LON:AZN) Receives Buy Rating from Berenberg Bank",
        "description":"AstraZeneca (LON:AZN \u2013 Get Free Report)\u2018s stock had its \u201cbuy\u201d rating reaffirmed by Berenberg Bank in a research report issued on Monday, MarketBeat Ratings reports. They currently have a \u00a3150 ($197.24) target price on the biopharmaceutical company\u2019s stock. Be\u2026",
        "content":"AstraZeneca (LON:AZN \u2013 Get Free Report)\u2018s stock had its \u201cbuy\u201d rating reaffirmed by Berenberg Bank in a research report issued on Monday, MarketBeat Ratings reports. They currently have a \u00a3150 ($197.2\u2026 [+2626 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/04\/astrazeneca-lonazn-receives-buy-rating-from-berenberg-bank\/",
        "source":"ETF Daily News",
        "published_at":1725427723000,
        "collected_at":1727696449297,
        "sentiment_label":"Positive",
        "sentiment_probabolity":0.9999983311,
        "sentiment_vector":0.9999983311
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Addison Advisors LLC Boosts Stake in AstraZeneca PLC (NASDAQ:AZN)",
        "description":"Addison Advisors LLC increased its stake in shares of AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 46.6% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,557 shares of the comp\u2026",
        "content":"Addison Advisors LLC increased its stake in shares of AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 46.6% in the 2nd quarter, according to the company in its most recent filing with the Securities &a\u2026 [+4838 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/07\/addison-advisors-llc-boosts-stake-in-astrazeneca-plc-nasdaqazn\/",
        "source":"ETF Daily News",
        "published_at":1725716929000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9973518848,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca PLC (NASDAQ:AZN) Shares Acquired by Norden Group LLC",
        "description":"Norden Group LLC boosted its stake in shares of AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 31.3% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,932 shares of th\u2026",
        "content":"Norden Group LLC boosted its stake in shares of AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 31.3% during the 2nd quarter, according to the company in its most recent filing with the Securities and \u2026 [+5275 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/09\/astrazeneca-plc-nasdaqazn-shares-acquired-by-norden-group-llc\/",
        "source":"ETF Daily News",
        "published_at":1725886728000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999959469,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca-Daiichi Sankyo drug shows survival trend in NSCLC trial",
        "description":"AstraZeneca-Daiichi Sankyo drug shows survival trend in NSCLC trial",
        "content":"WILMINGTON, Del. - AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo's datopotamab deruxtecan (Dato-DXd) has shown a trend toward improving overall survival (OS) compared with chemotherapy in a Phase III t\u2026 [+5073 chars]",
        "url":"https:\/\/www.investing.com\/news\/company-news\/astrazenecadaiichi-sankyo-drug-shows-survival-trend-in-nsclc-trial-93CH-3607883",
        "source":"Investing.com",
        "published_at":1725904639000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999536276,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca PLC (NASDAQ:AZN) Short Interest Down 27.2% in September",
        "description":"AstraZeneca PLC (NASDAQ:AZN \u2013 Get Free Report) was the target of a significant drop in short interest in September. As of September 15th, there was short interest totalling 6,450,000 shares, a drop of 27.2% from the August 31st total of 8,860,000 shares. Base\u2026",
        "content":"AstraZeneca PLC (NASDAQ:AZN \u2013 Get Free Report) was the target of a significant drop in short interest in September. As of September 15th, there was short interest totalling 6,450,000 shares, a drop o\u2026 [+4614 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/27\/astrazeneca-plc-nasdaqazn-short-interest-down-27-2-in-september\/",
        "source":"ETF Daily News",
        "published_at":1727464607000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9054996967,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Renaissance Technologies LLC Sells 632,444 Shares of AstraZeneca PLC (NASDAQ:AZN)",
        "description":"Renaissance Technologies LLC lessened its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 91.7% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 57,500 shares o\u2026",
        "content":"Renaissance Technologies LLC lessened its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 91.7% during the second quarter, according to the company in its most recent filing with the Securi\u2026 [+138 chars]",
        "url":"https:\/\/biztoc.com\/x\/4b607fad50982283",
        "source":"Biztoc.com",
        "published_at":1727509487000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.999976635,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Renaissance Technologies LLC Sells 632,444 Shares of AstraZeneca PLC (NASDAQ:AZN)",
        "description":"Renaissance Technologies LLC reduced its holdings in shares of AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 91.7% during the second quarter, HoldingsChannel reports. The firm owned 57,500 shares of the company\u2019s stock after selling 632,444 shares during the \u2026",
        "content":"Renaissance Technologies LLC reduced its holdings in shares of AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 91.7% during the second quarter, HoldingsChannel reports. The firm owned 57,500 shares of \u2026 [+4898 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/28\/renaissance-technologies-llc-sells-632444-shares-of-astrazeneca-plc-nasdaqazn\/",
        "source":"ETF Daily News",
        "published_at":1727508654000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999395609,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Mackenzie Financial Corp Grows Holdings in AstraZeneca PLC (NASDAQ:AZN)",
        "description":"Mackenzie Financial Corp boosted its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 9.3% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 307,9\u2026",
        "content":"Mackenzie Financial Corp boosted its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 9.3% in the second quarter, according to the company in its most recent 13F filing with the Se\u2026 [+137 chars]",
        "url":"https:\/\/biztoc.com\/x\/34f25e7a2fe9c072",
        "source":"Biztoc.com",
        "published_at":1727603167000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999753237,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca (LON:AZN) Given \u201cHold\u201d Rating at Deutsche Bank Aktiengesellschaft",
        "description":"Deutsche Bank Aktiengesellschaft reissued their hold rating on shares of AstraZeneca (LON:AZN \u2013 Free Report) in a report released on Tuesday morning, MarketBeat Ratings reports. Deutsche Bank Aktiengesellschaft currently has a \u00a3110 ($144.64) target price on t\u2026",
        "content":"Deutsche Bank Aktiengesellschaft reissued their hold rating on shares of AstraZeneca (LON:AZN \u2013 Free Report) in a report released on Tuesday morning, MarketBeat Ratings reports. Deutsche Bank Aktieng\u2026 [+2793 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/04\/astrazeneca-lonazn-given-hold-rating-at-deutsche-bank-aktiengesellschaft\/",
        "source":"ETF Daily News",
        "published_at":1725430976000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9639673829,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca PLC (NASDAQ:AZN) Shares Bought by Crossmark Global Holdings Inc.",
        "description":"Crossmark Global Holdings Inc. grew its stake in AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 3.3% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 40,482 shares of the c\u2026",
        "content":"Crossmark Global Holdings Inc. grew its stake in AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 3.3% during the 2nd quarter, according to the company in its most recent disclosure with the Securities \u2026 [+4770 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/08\/31\/astrazeneca-plc-nasdaqazn-shares-bought-by-crossmark-global-holdings-inc\/",
        "source":"ETF Daily News",
        "published_at":1725110211000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999452829,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca (LON:AZN) Sets New 12-Month High at $13,372.00",
        "description":"AstraZeneca PLC (LON:AZN \u2013 Get Free Report) shares reached a new 52-week high on Monday . The stock traded as high as \u00a3133.72 ($175.83) and last traded at \u00a3132.42 ($174.12), with a volume of 19909291 shares trading hands. The stock had previously closed at \u00a31\u2026",
        "content":"AstraZeneca PLC (LON:AZN \u2013 Get Free Report) shares reached a new 52-week high on Monday . The stock traded as high as \u00a3133.72 ($175.83) and last traded at \u00a3132.42 ($174.12), with a volume of 19909291\u2026 [+2758 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/04\/astrazeneca-lonazn-sets-new-12-month-high-at-13372-00\/",
        "source":"ETF Daily News",
        "published_at":1725441052000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9995399714,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Erste Group raises AstraZeneca stock to Buy on strong pipeline",
        "description":"Erste Group raises AstraZeneca stock to Buy on strong pipeline",
        "content":"AstraZeneca (NASDAQ: NASDAQ:AZN) has received an upgrade from Erste Group, moving from a Hold to a Buy rating. The pharmaceutical giant, known for its extensive research efforts, has been recognized \u2026 [+3934 chars]",
        "url":"https:\/\/www.investing.com\/news\/company-news\/erste-group-raises-astrazeneca-stock-to-buy-on-strong-pipeline-93CH-3611226",
        "source":"Investing.com",
        "published_at":1726053949000,
        "collected_at":1727696449297,
        "sentiment_label":"Positive",
        "sentiment_probabolity":1.0,
        "sentiment_vector":1.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Erste Group gets more bullish on AstraZeneca, upgrades shares",
        "description":"See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor\u2026",
        "content":"Earnings calls, analyst events, roadshows and more",
        "url":"https:\/\/thefly.com\/permalinks\/entry.php\/id3981703\/AZN-Erste-Group-gets-more-bullish-on-AstraZeneca-upgrades-shares",
        "source":"Thefly.com",
        "published_at":1726051249000,
        "collected_at":1727696449297,
        "sentiment_label":"Positive",
        "sentiment_probabolity":0.9996416569,
        "sentiment_vector":0.9996416569
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca announces HIMALAYA trial demonstrated overall survival benefit",
        "description":"See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor\u2026",
        "content":"Earnings calls, analyst events, roadshows and more",
        "url":"https:\/\/thefly.com\/permalinks\/entry.php\/id3983711\/AZN-AstraZeneca-announces-HIMALAYA-trial-demonstrated-overall-survival-benefit",
        "source":"Thefly.com",
        "published_at":1726485177000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.7272897363,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Parallel Advisors LLC Purchases 1,983 Shares of AstraZeneca PLC (NASDAQ:AZN)",
        "description":"Parallel Advisors LLC increased its holdings in shares of AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 10.6% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 20,753 shares of the co\u2026",
        "content":"Parallel Advisors LLC increased its holdings in shares of AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 10.6% during the 2nd quarter, according to the company in its most recent 13F filing with the S\u2026 [+5361 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/16\/parallel-advisors-llc-purchases-1983-shares-of-astrazeneca-plc-nasdaqazn\/",
        "source":"ETF Daily News",
        "published_at":1726487558000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999467134,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Oppenheimer Asset Management Inc. Grows Position in AstraZeneca PLC (NASDAQ:AZN)",
        "description":"Oppenheimer Asset Management Inc. grew its position in shares of AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 1.4% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 88,619 shares of \u2026",
        "content":"Oppenheimer Asset Management Inc. grew its position in shares of AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 1.4% in the 2nd quarter, according to its most recent disclosure with the Securities and\u2026 [+5138 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/16\/oppenheimer-asset-management-inc-grows-position-in-astrazeneca-plc-nasdaqazn\/",
        "source":"ETF Daily News",
        "published_at":1726479300000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.995644331,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Point72 DIFC Ltd Raises Holdings in AstraZeneca PLC (NASDAQ:AZN)",
        "description":"Point72 DIFC Ltd grew its holdings in AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 216.3% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 36,550 shares of the company\u2019s \u2026",
        "content":"Point72 DIFC Ltd grew its holdings in AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 216.3% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities &amp; Exc\u2026 [+4939 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/24\/point72-difc-ltd-raises-holdings-in-astrazeneca-plc-nasdaqazn\/",
        "source":"ETF Daily News",
        "published_at":1727196845000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999878407,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Holistic Financial Partners Sells 570 Shares of AstraZeneca PLC (NASDAQ:AZN)",
        "description":"Holistic Financial Partners trimmed its stake in AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 8.9% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,831 shar\u2026",
        "content":"Holistic Financial Partners trimmed its stake in AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 8.9% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exch\u2026 [+4842 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/01\/holistic-financial-partners-sells-570-shares-of-astrazeneca-plc-nasdaqazn\/",
        "source":"ETF Daily News",
        "published_at":1725201926000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.999987483,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"JPMorgan Chase & Co. Reiterates Overweight Rating for AstraZeneca (LON:AZN)",
        "description":"AstraZeneca (LON:AZN \u2013 Get Free Report)\u2018s stock had its \u201coverweight\u201d rating reaffirmed by investment analysts at JPMorgan Chase & Co. in a research note issued to investors on Monday, MarketBeat reports. Other analysts have also issued research reports about \u2026",
        "content":"AstraZeneca (LON:AZN \u2013 Get Free Report)\u2018s stock had its \u201coverweight\u201d rating reaffirmed by investment analysts at JPMorgan Chase &amp; Co. in a research note issued to investors on Monday, MarketBeat \u2026 [+2807 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/18\/jpmorgan-chase-co-reiterates-overweight-rating-for-astrazeneca-lonazn\/",
        "source":"ETF Daily News",
        "published_at":1726641165000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9514501691,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Axxcess Wealth Management LLC Cuts Holdings in AstraZeneca PLC (NASDAQ:AZN)",
        "description":"Axxcess Wealth Management LLC decreased its position in AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 11.5% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 21,075 shares of the company\u2019s stock after sell\u2026",
        "content":"Axxcess Wealth Management LLC decreased its position in AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 11.5% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. Th\u2026 [+4789 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/19\/axxcess-wealth-management-llc-cuts-holdings-in-astrazeneca-plc-nasdaqazn\/",
        "source":"ETF Daily News",
        "published_at":1726753525000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.562826097,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca PLC (OTCMKTS:AZNCF) Sees Large Growth in Short Interest",
        "description":"AstraZeneca PLC (OTCMKTS:AZNCF \u2013 Get Free Report) was the target of a large growth in short interest in September. As of September 15th, there was short interest totalling 42,100 shares, a growth of 352.7% from the August 31st total of 9,300 shares. Based on \u2026",
        "content":"AstraZeneca PLC (OTCMKTS:AZNCF \u2013 Get Free Report) was the target of a large growth in short interest in September. As of September 15th, there was short interest totalling 42,100 shares, a growth of \u2026 [+2198 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/25\/astrazeneca-plc-otcmktsazncf-sees-large-growth-in-short-interest\/",
        "source":"ETF Daily News",
        "published_at":1727291780000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999353886,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca PLC (NASDAQ:AZN) Shares Sold by Marshall Wace LLP",
        "description":"Marshall Wace LLP cut its position in shares of AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 48.7% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor own\u2026",
        "content":"Marshall Wace LLP cut its position in shares of AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 48.7% in the second quarter, according to the company in its most recent disclosure with the Securities a\u2026 [+4828 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/26\/astrazeneca-plc-nasdaqazn-shares-sold-by-marshall-wace-llp\/",
        "source":"ETF Daily News",
        "published_at":1727376407000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.999964118,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Sfmg LLC Sells 991 Shares of AstraZeneca PLC (NASDAQ:AZN)",
        "description":"Sfmg LLC cut its stake in shares of AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 26.0% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,815 shares of the company\u2019s stock after selling 991 shares dur\u2026",
        "content":"Sfmg LLC cut its stake in shares of AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 26.0% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,81\u2026 [+4861 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/26\/sfmg-llc-sells-991-shares-of-astrazeneca-plc-nasdaqazn\/",
        "source":"ETF Daily News",
        "published_at":1727381806000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999916553,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca PLC (NASDAQ:AZN) Shares Acquired by SAL Trading LLC",
        "description":"SAL Trading LLC increased its position in AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 337.2% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 78,702 shares o\u2026",
        "content":"SAL Trading LLC increased its position in AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 337.2% in the second quarter, according to the company in its most recent Form 13F filing with the Securities a\u2026 [+5057 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/28\/astrazeneca-plc-nasdaqazn-shares-acquired-by-sal-trading-llc\/",
        "source":"ETF Daily News",
        "published_at":1727560218000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9977244735,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Stocks in news: Infosys, Dixon Tech, AstraZeneca Pharma, HAL, GMR Airports",
        "description":"Stocks in news: Domestic markets started the week on a subdued note, ending nearly flat. Key stocks in focus include Infosys, Dixon Tech, AstraZeneca Pharma, HAL, and GMR Airports due to various developments. Notable updates include Infosys employees cleared \u2026",
        "content":"Domestic markets began the week on a subdued note and ended nearly flat, pausing after Friday's decline. In today's trade, shares of Infosys, Dixon Tech, AstraZeneca Pharma, HAL, GMR Airports among o\u2026 [+2310 chars]",
        "url":"https:\/\/economictimes.indiatimes.com\/markets\/stocks\/news\/stocks-in-news-infosys-dixon-tech-astrazeneca-pharma-hal-gmr-airports\/articleshow\/113209277.cms",
        "source":"The Times of India",
        "published_at":1725932149000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999909401,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca Pharma shares rally 13%, hit 52-week high after receiving nod for cancer drug Durvalumab",
        "description":"The stock is trading above its 5-day, 10-day, 20-day, 30-day, 50-day, 100-day, 150-day, and 200-day simple moving averages (SMAs).",
        "content":"(What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2024 and expert advice, on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets\u2026 [+317 chars]",
        "url":"https:\/\/economictimes.indiatimes.com\/markets\/stocks\/news\/astrazeneca-pharma-shares-rally-13-hit-52-week-high-after-receiving-nod-for-cancer-drug-durvalumab\/articleshow\/113621644.cms",
        "source":"The Times of India",
        "published_at":1727158276000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9913968444,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"International Assets Investment Management LLC Acquires New Stake in AstraZeneca PLC (NASDAQ:AZN)",
        "description":"International Assets Investment Management LLC acquired a new stake in AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional inv\u2026",
        "content":"International Assets Investment Management LLC acquired a new stake in AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) during the 2nd quarter, according to the company in its most recent disclosure with t\u2026 [+4728 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/01\/international-assets-investment-management-llc-acquires-new-stake-in-astrazeneca-plc-nasdaqazn\/",
        "source":"ETF Daily News",
        "published_at":1725191328000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999521971,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca In Trouble For Employee Detentions in China Over Illegal Activities",
        "description":"Chinese authorities have detained five current and former employees of AstraZeneca Plc (NASDAQ:AZN) as part of a broader investigation into alleged illegal activities in the pharmaceutical sector.\nThe investigation focuses on potential breaches of data privac\u2026",
        "content":"Chinese authorities have detained five current and former employees of AstraZeneca Plc (NASDAQ:AZN) as part of a broader investigation into alleged illegal activities in the pharmaceutical sector.The\u2026 [+137 chars]",
        "url":"https:\/\/biztoc.com\/x\/f65b98cbc154a564",
        "source":"Biztoc.com",
        "published_at":1725558700000,
        "collected_at":1727696449297,
        "sentiment_label":"Negative",
        "sentiment_probabolity":0.9183349013,
        "sentiment_vector":-0.9183349013
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"China detains five AstraZeneca staff in investigation over \u2018data privacy and import breaches\u2019",
        "description":"Detentions of current and former workers involve Chinese citizens who marketed cancer drugs for firm\u2019s oncology division\nChinese police have reportedly detained five current and former AstraZeneca employees as part of an investigation into possible breaches r\u2026",
        "content":"Detentions of current and former workers involve Chinese citizens who marketed cancer drugs for firms oncology divisionChinese police have reportedly detained five current and former AstraZeneca empl\u2026 [+136 chars]",
        "url":"https:\/\/biztoc.com\/x\/d168cc582a59cced",
        "source":"Biztoc.com",
        "published_at":1725546182000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.7419291139,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Founders Financial Securities LLC Buys 684 Shares of AstraZeneca PLC (NASDAQ:AZN)",
        "description":"Founders Financial Securities LLC lifted its stake in shares of AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 5.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,\u2026",
        "content":"Founders Financial Securities LLC lifted its stake in shares of AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 5.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities\u2026 [+4721 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/05\/founders-financial-securities-llc-buys-684-shares-of-astrazeneca-plc-nasdaqazn\/",
        "source":"ETF Daily News",
        "published_at":1725532974000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9998955727,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst",
        "description":"HC Wainwright initiated coverage on Enliven Therapeutics, Inc. (NASDAQ:ELVN) and noted the company as an emerging biotech company developing next-gen precision-oriented small molecules for solid and liquid tumor indications.\nEnliven\u2019s pipeline includes:\nELVN-\u2026",
        "content":"HC Wainwright initiated coverage on Enliven Therapeutics, Inc. (NASDAQ:ELVN) and noted the company as an emerging biotech company developing next-gen precision-oriented small molecules for solid and \u2026 [+122 chars]",
        "url":"https:\/\/biztoc.com\/x\/b5c78b3c04b27313",
        "source":"Biztoc.com",
        "published_at":1725913989000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999752045,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca shares fall 5% on disappointing lung cancer drug trial results",
        "description":"AstraZeneca shares fell more than 5% Tuesday morning, the biggest one-day drop in seven months, after the British pharmaceutical giant announced disappointing lung cancer drug trial results.",
        "content":"AstraZeneca shares fell more than 5% Tuesday morning, the biggest one-day drop in seven months, after the British pharmaceutical giant announced disappointing lung cancer drug trial results.\r\nThis st\u2026 [+36 chars]",
        "url":"https:\/\/biztoc.com\/x\/d3bebae0230edd22",
        "source":"Biztoc.com",
        "published_at":1725958621000,
        "collected_at":1727696449297,
        "sentiment_label":"Negative",
        "sentiment_probabolity":0.9999989271,
        "sentiment_vector":-0.9999989271
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca CEO Pascal Soriot Updates On Chinese Compliance Probe And Lung Cancer Drug Trial Results",
        "description":"Recently, Chinese authorities detained some current and former employees of AstraZeneca Plc (NASDAQ:AZN) as part of a broader investigation into alleged illegal activities in the pharmaceutical sector.\nThe investigation focuses on potential breaches of data p\u2026",
        "content":"Recently, Chinese authorities detained some current and former employees of AstraZeneca Plc (NASDAQ:AZN) as part of a broader investigation into alleged illegal activities in the pharmaceutical secto\u2026 [+127 chars]",
        "url":"https:\/\/biztoc.com\/x\/280cb8de9c018210",
        "source":"Biztoc.com",
        "published_at":1725975276000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.7779118419,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"AstraZeneca (LON:AZN) Shares Pass Above Two Hundred Day Moving Average of $11,865.94",
        "description":"AstraZeneca PLC (LON:AZN \u2013 Get Free Report)\u2019s share price passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of \u00a3118.66 ($155.17) and traded as high as \u00a3124.24 ($162.47). AstraZeneca shares last traded a\u2026",
        "content":"AstraZeneca PLC (LON:AZN \u2013 Get Free Report)\u2019s share price passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of \u00a3118.66 ($155.17) and traded as\u2026 [+2742 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/11\/astrazeneca-lonazn-shares-pass-above-two-hundred-day-moving-average-of-11865-94\/",
        "source":"ETF Daily News",
        "published_at":1726043466000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999992847,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Frank Rimerman Advisors LLC Buys 9,756 Shares of AstraZeneca PLC (NASDAQ:AZN)",
        "description":"Frank Rimerman Advisors LLC increased its stake in shares of AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 25,673.7% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 9,794 shares of the company\u2019s stock af\u2026",
        "content":"Frank Rimerman Advisors LLC increased its stake in shares of AstraZeneca PLC (NASDAQ:AZN \u2013 Free Report) by 25,673.7% during the 2nd quarter, according to the company in its most recent filing with th\u2026 [+4852 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/24\/frank-rimerman-advisors-llc-buys-9756-shares-of-astrazeneca-plc-nasdaqazn\/",
        "source":"ETF Daily News",
        "published_at":1727183304000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9997668862,
        "sentiment_vector":0.0
    },
    {
        "company":"AstraZeneca",
        "ticker":"AZN",
        "title":"Point72 Hong Kong Ltd Makes New Investment in AstraZeneca PLC (NASDAQ:AZN)",
        "description":"Point72 Hong Kong Ltd acquired a new position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 6,637 shares of the company's stock, valued at approxima\u2026",
        "content":"Point72 Hong Kong Ltd acquired a new position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm acqui\u2026 [+136 chars]",
        "url":"https:\/\/biztoc.com\/x\/512a6bcee867a69d",
        "source":"Biztoc.com",
        "published_at":1727430523000,
        "collected_at":1727696449297,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999965429,
        "sentiment_vector":0.0
    }
]